Early Phase II Clinical Study of TS-142 in Patients with Insomnia

Authors
Category Primary study
Registry of TrialsJapan Pharmaceutical Information Center
Year 2017
INTERVENTION: Intervention name : TS‐142 Dosage And administration of the intervention : Once a day Control intervention name : Placebo Dosage And administration of the control intervention : Once a day CONDITION: Insomnia PRIMARY OUTCOME: latency to persistent sleep and wakefulness after sleep once by polysomnography(PSG) INCLUSION CRITERIA: ‐ Diagnosis of insomnia disorder ‐ Outpatient etc.
Epistemonikos ID: 2ffe6ff4fc5b59f29175324dd93462a586161ba5
First added on: Aug 23, 2024